MESO FY 2015 Earnings — Mesoblast Limited Revenue & Financial Results | Market Cap Arena

MESOMesoblast Limited

$2B

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$24M-8.6% YoY

Gross Profit

-$35,000-0.1% margin

Operating Income

-$113M-477.5% margin

Net Income

-$119M-502.6% margin

EPS (Diluted)

$-2.20

Cash Flow

Operating Cash Flow

-$122M

Free Cash Flow

-$124M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$1.0B

Total Liabilities

$409M

Stockholders' Equity

$609M

Cash & Equivalents

$28M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$24M	$26M	-8.6%
Gross Profit	-$35,000	$546,000	-106.4%
Operating Income	-$113M	-$72M	-56.7%
Net Income	-$119M	-$81M	-47.4%